by David Cassak
Eugene Kleiner, founder of the powerhouse venture capital firm, Kleiner Perkins, and one of the fathers of venture capital, once supposedly said something to the effect that venture dollars are...
Endosense: Facing Technology and Financing Challenges in AF
Endosense is beginning to establish itself in the tough market of atrial fibrillation with a catheter that stresses an attribute that no one has featured yet: force sensing in delivering energy. Proving the clinical value of force-sensing will be difficult enough, but Endosense faced an even greater challenge in 2009 when its long-time backer, 3i, decided it wanted to exit device venture investing and divest its stake in the company.